SCHEMBL4880462

SCHEMBL4880462

OCCCC(CO)(CO)CCCO

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
TSHR P16473 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ARG2 P78540 1/20 0.32
DPP4 P27487 1/20 0.32
GPR84 Q9NQS5 1/20 0.30
FFAR1 O14842 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28573457 0.94 ALDH1A1 (0.33) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL3871791 0.93 ALDH1A1 (0.37) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL15694681 0.93 ALDH1A1 (0.37) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL4318074 0.90 ALDH1A1 (0.35) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL2418354 0.87 ALDH1A1 (0.38) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL28260375 0.86
SCHEMBL15800756 0.86 ALDH1A1 (0.35) ALDH1A1TSHRARG2
1,4-Butanediol SCHEMBL7859266 0.85 TSHR (0.41) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL1012045 0.85 SMN1; SMN2 (0.41) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10
SCHEMBL435370 0.82 SMN1; SMN2 (0.43) ALDH1A1TSHRSMN1; SMN2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080182919-A1 Dental Restorative Composition SUN MEDICAL CO., LTD. (JP) 2008-07-31 US disclosed
EP-1854447-A1 DENTAL RESTORATION MATERIAL COMPOSITION SUN MEDICAL CO., LTD. (JP) 2007-11-14 EP disclosed
EP-0710684-B1 Preparation process of polyhydroxycarboxylic acid MITSUI CHEMICALS INC (JP) 2001-01-31 EP disclosed
US-5770683-A Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, INC. (JP) 1998-06-23 US disclosed
EP-0710684-A2 Preparation process of polyhydroxycarboxylic acid MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-05-08 EP disclosed
US-5417983-A Acrylate polymer SAGAMI CHEMICAL RESEARCH CENTER (JP) 1995-05-23 US disclosed
EP-0556818-A1 Polyester type polyfunctional macromonomer, gel and drug release controlling material responsive to changes in temperature SAGAMI CHEMICAL RESEARCH CENTER (JP) 1993-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182919-A1 Dental Restorative Composition PARG, PARN, FHIT ALDH1A1 3741/4885TSHR 3228/4885SMN1; SMN2 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.